SWZNF yields 0.43% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, SWZNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SWZNF + PFE for your $10,000?
Schweizerische Nationalbank, an independent central bank, provides banking services to the Swiss Confederation. The company implements its monetary policy by steering the interest rate level on the money market; supplies the Swiss economy with banknotes and coins commensurate with demand for payment purposes; distributes banknotes and coins; facilitates and secures the operation of cashless payment systems; and manages the currency reserves. It also analyses the sources of risk to the financial system and identifies areas where action is needed, and oversees financial market infrastructures, as well as facilitates the creation and implementation of a regulatory framework for the financial sector; and participates in international monetary cooperation and provides technical assistance. In addition, the company processes payments on behalf of the confederation; issues money market debt register claims and bonds; handles the custody of securities; and carries out foreign exchange transactions. Further, it compiles statistical data on banks and financial markets, the balance of payments, direct investment, the international investment position, and the Swiss financial accounts. The company was founded in 1907 and is headquartered in Bern, Switzerland.
Full SWZNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.